Effects of cilostazol on plasma adipocytokine and arterial stiffness in type 2 diabetes patient with metabolic syndrome (randomized, double-blind, placebo-controled, cross-over study)
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Cilostazol (Primary)
- Indications Embolism and thrombosis; Vascular disorders
- Focus Pharmacodynamics
- Acronyms cilostaar
- 02 Aug 2010 Status changed from completed to active, no longer recruiting.
- 22 Jun 2010 Results presente at the 92nd Annual Meeting of the Endocrine Society
- 22 Jun 2010 Status change from recruiting to active, no longer recruiting